• Exchange: EN Amsterdam
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GLPG:NA

14.6950 EUR 0.2950 2.05%

As of 07:54:16 ET on 07/30/2014.

Snapshot for Galapagos NV (GLPG)

Open: 14.4000 Day's Range: 14.4000 - 14.7000 Volume: 5,081
Previous Close: 14.4000 52wk Range: 13.2900 - 18.4200 1-Yr Rtn: -8.90%

Stock Chart for GLPG

No chart data available.
  • GLPG:NA 14.6950
  • 1D
  • 1M
  • 1Y
14.4000
Interactive GLPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. AEX -
Earnings Per Share (EUR) (ttm) -0.2800
Est. EPS (EUR) (12/2014) -0.6670
Est. PEG Ratio -
Market Cap (M EUR) 444.52
Shares Outstanding (M) 30.28
30 Day Average Volume 61,452
Price/Book (mrq) 2.6196
Price/Sale (ttm) 3.0721
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLPG

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GLPG

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Onno Van De StolpeCEO/Executive DirectorLaure VerhaegenInterim CFO/VP:Finance
Piet WigerinckChief Scientific OfficerDavid SmithCEO:Service Division
More Company Profile & Key Executives for GLPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil